[go: up one dir, main page]

BR9510327A - Derivados de nucleosídeos e seu processo de preparo - Google Patents

Derivados de nucleosídeos e seu processo de preparo

Info

Publication number
BR9510327A
BR9510327A BR9510327A BR9510327A BR9510327A BR 9510327 A BR9510327 A BR 9510327A BR 9510327 A BR9510327 A BR 9510327A BR 9510327 A BR9510327 A BR 9510327A BR 9510327 A BR9510327 A BR 9510327A
Authority
BR
Brazil
Prior art keywords
preparation process
nucleoside derivatives
nucleoside
derivatives
preparation
Prior art date
Application number
BR9510327A
Other languages
English (en)
Inventor
Hong Ryul Lee
Jung Woo Kim
Original Assignee
Chong Kun Dang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019940027067A external-priority patent/KR960014116A/ko
Priority claimed from KR1019940027068A external-priority patent/KR960014117A/ko
Priority claimed from KR1019950002124A external-priority patent/KR960031456A/ko
Application filed by Chong Kun Dang Corp filed Critical Chong Kun Dang Corp
Publication of BR9510327A publication Critical patent/BR9510327A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR9510327A 1994-10-22 1995-10-21 Derivados de nucleosídeos e seu processo de preparo BR9510327A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR1019940027067A KR960014116A (ko) 1994-10-22 1994-10-22 새로운 1,4-디옥산 유도체 및 그 제조방법
KR1019940027068A KR960014117A (ko) 1994-10-22 1994-10-22 새로운 1,4-옥사티안 유도체 및 그 제조방법
KR1019950002124A KR960031456A (ko) 1995-02-07 1995-02-07 새로운 테트라하이드로피란 유도체 및 그 제조방법
PCT/KR1995/000135 WO1996012716A1 (en) 1994-10-22 1995-10-21 Nucleoside derivatives and process for preparing thereof

Publications (1)

Publication Number Publication Date
BR9510327A true BR9510327A (pt) 1998-11-10

Family

ID=27349107

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9510327A BR9510327A (pt) 1994-10-22 1995-10-21 Derivados de nucleosídeos e seu processo de preparo

Country Status (7)

Country Link
US (1) US6034087A (pt)
EP (1) EP0869953A1 (pt)
JP (1) JP3047045B2 (pt)
AU (1) AU3710395A (pt)
BR (1) BR9510327A (pt)
CA (1) CA2203262A1 (pt)
WO (1) WO1996012716A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2826505A1 (en) * 2001-05-18 2002-11-28 Rakesh Kumar Antiviral nucleosides
CN107266403A (zh) * 2016-04-08 2017-10-20 捷恩智株式会社 四氢‑2h‑吡喃衍生物的制造方法、中间物、及其衍生物
CN117551100B (zh) * 2024-01-12 2024-03-12 苏州诺维康生物科技有限公司 (s)-9-[3-(4,4'-双甲氧基三苯甲基)-2-羟基丙基]-n2-乙酰基鸟嘌呤的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85952A1 (fr) * 1985-06-14 1987-01-13 Oreal Nouveaux composes hemiacetaliques et leurs applications
AU9125991A (en) * 1990-12-05 1992-07-08 University Of Georgia Research Foundation, Inc., The Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
GB9311709D0 (en) * 1993-06-07 1993-07-21 Iaf Biochem Int Stereoselective synthesis of nucleoside analogues using bicycle intermediate
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
US5736549A (en) * 1994-10-05 1998-04-07 Chiroscience Limited Hypoxanthine and guanine compounds

Also Published As

Publication number Publication date
US6034087A (en) 2000-03-07
JP3047045B2 (ja) 2000-05-29
AU3710395A (en) 1996-05-15
WO1996012716A1 (en) 1996-05-02
MX9702886A (es) 1998-05-31
CA2203262A1 (en) 1996-05-02
EP0869953A1 (en) 1998-10-14
JPH10500994A (ja) 1998-01-27

Similar Documents

Publication Publication Date Title
BR9404114A (pt) Composição farmacêutica e seu processo de preparação
BR9506147A (pt) Novos derivados de eritromicina seu processo de preparação e sua aplicação como medicamentos
BR9504561A (pt) Processo de fabricaçao de restriçao e restriçao
FI941137A (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
PT685593E (pt) Celulose sulfonada e seu processo de preparacao
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
BR9400475A (pt) Processo de preparação de zeólita modificada e zeólita modificada
PT712860E (pt) Processo para purificacao e isolamento de 2'-deoxi-2', 2'-difluoronucleosidos
BR9001859A (pt) Processo de fabricacao de embolo e embolo
BR9707709A (pt) Derivados da eritromicina seu processo de preparação e sua aplicação como medicamentos
BR9605760A (pt) Aperfeiçoamento de processo na síntese de n-Ú3-(3-ciano pirazoloÚ1,5-A¾pirimidin-7-il)fenil¾-n-etil acetamida
BR9607958A (pt) Tomada de não interrupção e processo
BR9606396A (pt) Derivados de camptotecin substituídos e processo para sua preparação
BR9002736A (pt) Curral dobravel aperfeicoado e seu processo de montagem
BR9005438A (pt) Poliaminas e seu processo de preparacao
BR9707613A (pt) Misturas isentas de derivados poliferólicos processo de pre paração de misturas i e ii medicamentos e utilização das misturas
BR9506020A (pt) Composição aquosa e processo de preparaçao da mesma
BR9305547A (pt) Zeólito y desaluminizado e seu processo de preparação
BR9611573A (pt) Processo de preparação de derivados de fenilimidazolidina
BR9408530A (pt) Intermediário e processo para preparação
BR9506065A (pt) Edulcorante cozido sem sçúcar e seu processo de preparação
PT915874E (pt) Processo de preparacao de valaciclovir e intermediarios relevantes
BR9502384A (pt) Processo de reconstituiçao de tabaco
BR8901342A (pt) Polidiorganosiloxano e processo de preparacao do mesmo

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law